Sydney Health Ethics: Recent submissions
-
Overdiagnosis: an important issue that demands rigour and precision: Comment on Medicalisation and overdiagnosis: what society does to medicine.
Published 2017-02-25Van Dijk and colleagues present three cases to illustrate and discuss the relationship between medicalisation and overdiagnosis. In this commentary, I consider each of the case studies in turn, and in doing so emphasise ...Article -
Accelerated access to medicines: An ethical analysis
Published 2017-01-01In recent years, a range of initiatives have been introduced to provide patients with access to medicines outside of traditional regulatory and/or funding channels; we term these processes “accelerated access to medicines”. ...Article -
Faster access to new drugs doesn’t always mean better treatment
Published 2017-03-15US President Donald Trump recently chose an adviser to a large pharmaceutical company to lead the country’s drug regulation agency. Scott Gottlieb – who reportedly sits on the boards of several small drug companies and is ...Article -
Public preferences for communicating personal genomic risk information: a focus group study
Published 2016-12-01Background: Personalized genomic risk information has the potential to motivate behaviour change and promote population health, but the success of this will depend upon effective risk communication strategies. Objective: ...Article -
Exploring the potential emotional and behavioural impact of providing personalised genomic risk information to the public: a focus group study
Published 2015-01-01Aim: To explore the potential emotional and behavioural impact of providing information on personalised genomic risk to the public, using melanoma as an example, to aid research translation. Methods: We conducted four ...Article